A groundbreaking new drug has been approved on the NHS, and it could benefit hundreds suffering from one of the most aggressive forms of breast cancer.
It’s been revealed this week that NHS bosses have struck a deal with the manufacturers of the drug pembrolizumab, and have now been given the greenlight to treat around 1,600 patients in England who are suffering from triple negative breast cancer – which is one of the rarest and most aggressive forms of the disease.
Triple negative breast cancer accounts for around 15% of all cases, and is responsible for a quarter of all breast cancer deaths.
According to the charity Breast Cancer Now – which promotes cancer research, and offers support to sufferers – triple negative breast cancer is a particularly common form in those under 40, black women, and those who have inherited the BRCA gene.
Triple negative breast cancer patients have a shorter survival time than those with other forms of the disease, and typically, the risk of it returning and spreading to other parts of the body in the first few years after treatment is higher than for other cancer suffers.
ADVERTISEMENT
But now, scientists say that for those taking the new drug – which is a form of immunotherapy, and will be used alongside chemotherapy before surgery – the likelihood that the cancer will disappear, and the time before cancer returns, will increase.
Pembrolizumab will be one of just a few treatments that currently exist for triple negative breast cancer.
ADVERTISEMENT
Up to 1,600 of those affected by high risk triple-negative breast cancer a year are set to benefit from access to the treatment, called pembrolizumab, on the NHS.
Amanda Pritchard, the chief executive of NHS England, said the rollout of pembrolizumab – which she called “an innovative, potentially life-saving treatment” – was “fantastic news”, and said that it represented “a hugely significant moment for women”.
“It will give hope to those who are diagnosed and prevent the cancer from progressing, allowing people to live normal, healthy lives,” she added.
Breast Cancer Now has also hailed the approval of the new treatment.
“This new treatment can potentially lead to any detectable cancer disappearing by the time of surgery, meaning patients will then possibly face less invasive, breast-conserving surgery,” said Baroness Delyth Morgan, chief executive of Breast Cancer Now.
“By significantly reducing the likelihood of breast cancer recurring or spreading to other parts of the body where it becomes incurable secondary breast cancer, this treatment brings precious hope of more lives potentially being saved from this devastating disease.”
NHS launches new AI and robot cancer detection pilot offering ‘glimpse into future’
Emily Sergeant
The NHS has launched a ‘trailblazing’ new AI and robot pilot to help spot cancers sooner.
Patients who are facing suspected lung cancer could get answers sooner under the new pilot that makes use of artificial intelligence (AI) and robotic technology to help doctors reach hard-to-detect cancers earlier, and all without with fewer tests too.
At the moment, patients are faced with weeks of repeat scans and procedures to come to a diagnosis.
But this could soon be replaced with a single, half-hour cancer biopsy – reducing prolonged uncertainty, and avoiding more invasive surgery.
According to the NHS, the new approach uses AI software to rapidly analyse lung scans and flag small lumps that are most likely to be cancerous, before a robotic camera is then used to guide biopsy tools through the airways with much greater precision than standard techniques.
A new NHS pilot using AI and robotic technology will help doctors reach hard-to-detect lung cancers earlier.
Weeks of scans and procedures could be replaced with a single biopsy, reducing uncertainty and avoiding more invasive surgery.
The robot can reach nodules as small as 6mm – which is around the size of a grain of rice – that are hidden deep in the lung and are often deemed too risky or difficult to access using existing methods, and once AI has highlighted higher-risk areas, doctors can then take a precise tissue sample, which is sent to specialist laboratories and reviewed by expert cancer teams to confirm or rule out cancer.
The NHS’s top cancer doctor hailed the pilot – which is currently being carried out at Guy’s and St Thomas’ NHS Foundation Trust – as ‘a glimpse of the future of cancer detection’.
“Waiting to find out if you might have cancer is incredibly stressful for patients and their families,” admitted Professor Peter Johnson, who is NHS England’s National Clinical Director for Cancer.
The NHS has launched a new AI and robot cancer detection pilot that’s offering a ‘glimpse into future’ / Credit: rawpixel
“Our lung cancer screening programme means that we are picking up more cancers at an early stage than ever, and by bringing AI and robotics together in this trailblazing NHS pilot, we’re bringing in the very latest technology to give clinicians a clearer look inside the lungs and support faster, more accurate biopsies.
“This is a glimpse of the future of cancer detection.
“Innovation like this is exactly how we can help diagnose more cancers faster, so treatment can be most effective, and why the NHS continues to lead the way in bringing new technology safely into frontline care.”
If successful, the pilot will help the NHS to generate evidence to develop a national commissioning policy for robotic bronchoscopy.
It will also support more consistent access to the technology across the NHS in future.
Featured Image – Tima Miroshnichenko (via Pexels)
News
Chester Zoo announces new spring date for its popular running event to help UK wildlife
Emily Sergeant
Chester Zoo has announced that its popular Run For Nature is back again this year, and this time, there’s a new spring edition.
The UK’s biggest charity zoo seen success with this event in the past few years, with thousands of runners signing up for one of the North West’s most unique athletic experiences and all funds raised going towards efforts to protect highly-endangered giraffes in Africa.
This year though, the much-loved event’s focus brings conservation ‘a little closer to home’ and will protect some of the UK’s most threatened species instead – with all funds helping to safeguard hedgehogs, kingfishers, otters, harvest mice, and more.
It comes as the UK is currently considered one of the most nature-depleted countries on Earth.
Participants will first get to wind through the zoo and enjoy glimpses of elephants, lemurs, and other incredible species along the way, before heading out into the picturesque Cheshire countryside.
Adults can choose from a 10K or 5K route, while younger runners are invited to take part in a one-mile ‘Zoom’ race, open to children aged four-15, which takes place entirely within the zoo’s incredible 130-acre grounds.
All runners will receive free entry to the zoo for the rest of the day as part of their registration, along with a 25% discount for friends and family who come along to show support.
Chester Zoo’s popular 10K charity run is returns with a new spring date / Credit: Chester Zoo
Lorraine Jubb, who is the Fundraising Lead at Chester Zoo, called the Run For Nature a ‘really special event’.
“In previous years, runners have already supported conservation efforts for Asian elephants, Eastern black rhinos and Northern giraffe,” she explained. This springtime though, we’re turning our attention much closer to home in the UK, and to the wildlife we share our gardens, parks and countryside with.
“With one in six species now at risk of extinction in the UK, every runner will be playing a vital role in helping us protect animals and supporting our growing nature recovery work across right across Cheshire.
Emily Sergeant -
8th November 2022 
